8 reports

Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, a market leader in virology and active in other major therapeutic areas such as autoimmune diseases, inflammation, metabolic disorders and diseases of the central nervous system.

  • Cancer Hormonal Therapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • RICOLINOSTAT - DRUG PROFILE

One is a phase I trial vorinostat with intravenous temsirolimus for patients with metastatic disease.

  • Cancer Hormonal Therapy
  • Oncology
  • United States
  • World
  • Acetylon Pharmaceuticals, Inc.

It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases.

  • Cancer Hormonal Therapy
  • Hormone
  • United States
  • World
  • Product Initiative

ITS OTHER CLINICAL PROGRAMMES INCLUDE TZLS-##, A HUMAN ENGINEERED ANTI-HUMAN CD## ANTIBODY INTENDED FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES.

  • Cancer Hormonal Therapy
  • Hepatitis
  • World
  • Product Initiative
  • Pfizer Inc.

It focuses on therapy areas such as respiratory; cardiovascular and metabolic disease (CVMD); and cancer, besides autoimmune, infection and neurological diseases.

  • Cancer Hormonal Therapy
  • Hormone
  • United States
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative

At the time of clinical cut-off, one death due to disease progression in the SHORT dosing cohort was confirmed.

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Oncology
  • World
  • Celgene Corporation

Only ## patient had progressive disease.

  • Cancer
  • Cancer Hormonal Therapy
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.